Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: A model for hyperprostaglandin E syndrome/antenatal Bartter syndrome

Journal of the American Society of Nephrology

Volumn 16, Issue 8, 2005, Pages 2354-2362

  Nüsing, Rolf M ^a,b   Treude, Antje ^a,b   Weissenberger, Christian ^a   Jensen, Boye ^c   Bek, Martin ^d   Wagner, Charlotte ^e   Narumiya, Shuh ^f   Seyberth, Hannsjörg W ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; RENIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARTTER SYNDROME; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; ELECTROLYTE EXCRETION; HYPERPROSTAGLANDIN E SYNDROME; KIDNEY TUBULE DISORDER; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN RELEASE; SODIUM DEPLETION; SODIUM EXCRETION; URINE VOLUME; WILD TYPE;

EID: 28444452562     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004070556     Document Type: Article

References (57)

1. Seyberth HW, Soergel M, Köckerling A: Hypokalaemic tubular disorders: The hyperprostaglandin E syndrome and the Gitelman-Bartter syndrome. In: Oxford Textbook of Clinical Nephrology, 2nd Ed., edited by Davison AM, Cameron JS, Grünfeld J-P, Kerr DNS, Ritz E, Oxford, Oxford University Press, 1998, pp 1085-1094
2. Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, Konrad M, Seyberth HW: Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112: 183-190, 2002
3. Simon DB, Karet FE, Hamdan JM, Dipietro A, Sanjad SA, Lifton RP: Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183-188, 1996
4. Schlingmann KP, Konrad M, Jeck N, Waldegger P, Reinalter SC, Holder M, Seyberth HW, Waldegger S: Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 350: 1314-1319, 2004
5. Estevez R, Boettger T, Stein V, Birkenhager R, Otto E, Hildebrandt F, Jentsch TJ: Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 414: 558-561, 2001
6. Seyberth HW, Königer SJ, Rascher W, Kühl PG, Schweer H: Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1: 491-497, 1987
7. Kömhoff M, Gröne HJ, Klein T, Seyberth HW, Nüsing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function. Am J Physiol 272: F460-F468, 1997
8. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA: Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension 29: 297-302, 1997
9. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD: Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994
10. Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J: Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol 279: F819-F825, 2000
11. Hartner A, Goppelt-Struebe M, Hilgers KF: Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension 31: 201-205, 1998
12. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC: Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999
13. Nüsing RM, Reinalter SC, Peters M, Kömhoff M, Seyberth HW: Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Clin Pharmacol Ther 70: 384-390, 2001
14. Kammerl MC, Nüsing RM, Richthammer W, Kramer BK, Kurtz A: Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int 60: 1684-1691, 2001
15. Kömhoff M, Jeck ND, Seyberth HW, Gröne HJ, Nüsing RM, Breyer MD: Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome. Kidney Int 58: 2420-2424, 2000
16. Kömhoff M, Reinalter SC, Grone HJ, Seyberth HW: Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res 19: 19, 2003
17. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM, Seyberth HW, Kömhoff M: Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 62: 253-260, 2002
18. Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999
19. Morath R, Klein T, Seyberth HW, Nüsing RM: Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 10: 1851-1860, 1999
20. Breyer MD, Breyer RM: G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 63: 579-605, 2001
21. Breyer MD, Davis L, Jacobson HR, Breyer RM: Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol 271: F912-F918, 1996
22. Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, Narumiya S: Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol 266: F823-F828, 1994
23. Purdy KE, Arendshorst WJ: EP[1] and EP[4] receptors mediate prostaglandin E[2] actions in the microcirculation of rat kidney. Am J Physiol Renal Physiol 279: F755-F764, 2000
24. Jensen BL, Stubbe J, Hansen PB, Andreasen D, Skott O: Localization of prostaglandin E[2] EP2 and EP4 receptors in the rat kidney. Am J Physiol Renal Physiol 280: F1001-F1009, 2001
25. Takeuchi K, Abe T, Takahashi N, Abe K: Molecular cloning and intrarenal localization of rat prostaglandin E2 receptor EP3 subtype. Biochem Biophys Res Commun 194: 885-891, 1993
26. Breyer MD, Jacobson HR, Davis LS, Breyer RM: In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor. Kidney Int 44:1372-1378, 1993
27. Taniguchi S, Watanabe T, Nakao A, Seki G, Uwatoko S, Kurokawa K: Detection and quantitation of EP3 prostaglandin E2 receptor mRNA along mouse nephron segments by RT-PCR. Am J Physiol 266: C1453-C1458, 1994
28. Mann B, Hartner A, Jensen BL, Kammerl M, Kramer BK, Kurtz A: Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 59: 62-68, 2001
29. Chen M, Schnermann J, Malvin RL, Killen PD, Briggs JP: Time course of stimulation of renal renin messenger RNA by furosemide. Hypertension 21: 36-41, 1993
30. Lane PH: Furosemide treatment, angiotensin II, and renal growth and development in the rat. Pediatr Res 37: 747-754, 1995
31. Lane PH: Long-term furosemide treatment in the normal rat: Dissociation of glomerular hypertrophy and glomerulosclerosis. Am J Kidney Dis 33: 1058-1063, 1999
32. Hizaki H, Segi E, Sugimoto Y, Hirose M, Saji T, Ushikubi F, Matsuoka T, Noda Y, Tanaka T, Yoshida N, Narumiya S, Ichikawa A: Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP[2]. Proc Natl Acad Sci U S A 96: 10501-10506, 1999
33. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Matsuoka T, Ushikubi F, Hirose M, Tanaka T, Yoshida N, Narumiya S, Ichikawa A: Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246: 7-12, 1998
34. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S: Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395: 281-284, 1998
35. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M, Ito K, Ito Y, Sugimoto Y, Ushikubi F, Ohuchida S, Kondo K, Nakamura T, Narumiya S: Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A 99: 4580-4585, 2002
36. Radeck W, Heller M: Improved method for the determination of furosemide in plasma by high-performance liquid chromatography. J Chromatogr 497: 367-370, 1989
37. Wagner C, Pfeifer A, Ruth P, Hofmann F, Kurtz A: Role of cGMP-kinase II in the control of renin secretion and renin expression. J Clin Invest 102: 1576-1582, 1998
38. Lykkegard S, Poulsen K: Ultramicroassay for plasma renin concentration in the rat using the antibody-trapping technique. Anal Biochem 75: 250-259, 1976
39. Freeman RH, Davies JO, Villarreal R: Role of renal prostaglandins in the control of renin release. Circ Res 54: 1-6, 1984
40. Jensen BL, Mann B, Skott O, Kurtz A: Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat. Kidney Int 56: 528-537, 1999
41. Cheng HF, Wang JL, Zhang MZ, Wang SW, McKanna JA, Harris RC: Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol Renal Physiol 280: F449-F456, 2001
42. Schweda F, Klar J, Narumiya S, Nusing RM, Kurtz A: Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol 287: F427-F433, 2004
43. Fujino T, Nakagawa N, Yuhki K, Hara A, Yamada T, Takayama K, Kuriyama S, Hosoki Y, Takahata O, Taniguchi T, Fukuzawa J, Hasebe N, Kikuchi K, Narumiya S, Ushikubi F, Xiao CY, Karibe H, Okada Y, Shiokoshi T, Ohsaki Y, Ma H, Iwashima Y, Murata T: Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin 12 receptor IP. J Clin Invest 114: 805-812, 2004
44. Schnermann J: Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 274: R263-R279, 1998
45. Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K: Congenital hypokalemia with hypercalciuria in preterm infants: A hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107: 694-701, 1985
46. Köckerling A, Reinalter S, Seyberth HW: Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the Loop of Henle. J Pediatr 129: 519-528, 1996
47. Guan Y, Zhang Y, Breyer RM, Fowler B, Davis L, Hebert RL, Breyer MD: Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. J Clin Invest 102: 194-201, 1998
48. Sonnenburg WK, Zhu JH, Smith WL: A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J Biol Chem 265: 8479-8483, 1990
49. Breyer MD, Jacobson HR, Breyer RM: Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol 7: 8-17, 1996
50. Knoers N, Monnens LA: Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr 117: 499-502, 1990
51. Hochberg Z, Even L, Danon A: Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency. Clin Endocrinol 49: 39-44, 1998
52. Wilson DR, Honrath U, Sonnenberg H: Furosemide action on collecting ducts: Effect of prostaglandin synthesis inhibition. Am J Physiol 244: F666-F673, 1983
53. Kirchner KA: Prostaglandin inhibitors alter loop segment chloride uptake during furosemide diuresis. Am J Physiol 248: F698-F704, 1985
54. Kaji DM, Chase HS, Eng JP, Diaz J: Prostaglandin E[2] inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. Am J Physiol 271: C354-C361, 1996
55. Liu HJ, Wei Y, Ferreri NR, Nasjletti A, Wang WH, Fererri NR: Vasopressin and PGE[2] regulate activity of apical 70 pS K(+) channel in thick ascending limb of rat kidney. Am J Physiol Cell Physiol 278: C905-C913, 2000
56. Fernandez-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, Nielsen S, Knepper MA: Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol 277: F219-F226, 1999
57. Silldorff EP, Yang S, Pallone TL: Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest 95: 2734-2740, 1995